Bottom line
Is GLCR a good fund? The bottom line
GLCR is an actively managed international stock ETF from Roundhill.
Annual fees run 0.95% — about $95 a year on every $10,000 invested, more expensive than 55% of international stock funds we track.
With $1.4 million in net assets and 32 holdings, its largest position is Islandsbanki HF (14.0%) and the top 10 make up 68% of the portfolio.
What to watch
- Concentrated: top 10 holdings are 68% of assets
- Small fund ($1.4 million) — small funds are likelier to close
Updated Nov 19, 2026
What GLCR invests in
The GlacierShares Nasdaq Iceland ETF (the Fund) seeks to track the total return performance, before fees and expenses, of an index composed of equity securities of Icelandic companies and companies related to the Icelandic economy.
The Fund employs a passive management (or indexing) investment approach designed to track the total return performance, before fees and expenses, of the MarketVector Iceland Global Index (the Index). MarketVector Iceland Global Index The Index, which is sub-index of the MarketVector Total Global Equity Index, tracks the performance of common stocks (or corresponding American Depositary Receipts (ADRs) or Global Depositary Receipts (GDRs)) of local Icelandic companies and non-local companies related to the Icelandic economy. Local Icelandic companies (i) are those companies assigned to the Iceland universe of the MarketVector Total Global Equity Index, (ii) have a listing on an exchange in Iceland and derive a significant portion (50% for initial consideration and 25% for continued eligibility after inclusion) of revenues or operating assets from Iceland or a Nordic Country ( i.e.…
From the fund's prospectus (filed Apr 29, 2026).
What GLCR costs
On a $10,000 investment, GLCR's 0.95% expense ratio costs about $95 a year. The prospectus estimates $1,166 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
GLCR top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Islandsbanki HF ISB | 13.95% |
| 2 | Arion Banki HF ARION | 13.20% |
| 3 | Oculis Holding AG OCS | 7.95% |
| 4 | Embla Medical HF EMBLA | 5.49% |
| 5 | JBT Marel Corp JBTM | 5.38% |
| 6 | Amaroq Ltd AMRQ | 5.32% |
| 7 | Alvotech SA ALVO | 4.56% |
| 8 | Bakkafrost P/F BAKKA | 4.22% |
| 9 | Mowi ASA MOWI | 4.15% |
| 10 | Salmar ASA SALM | 3.82% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 68% of the fund. See all top 25 holdings and asset mix →